硬皮病髓系细胞Fli1下调经Galectin-3/mTOR通路促进心脏纤维化
本研究探讨髓系细胞中转录因子Fli1下调是否促进系统性硬化症(SSc)心脏纤维化及其机制。SSc心肌Fli1降低约6倍、Gal-3升高约4倍;髓系特异性Fli1敲除小鼠出现心肌胶原增加和舒张功能障碍,老年小鼠收缩功能也受损;机制上Fli1缺失解除LGALS3启动子抑制,经Gal-3激活心脏成纤维细胞mTORC1。
要点
- SSc心肌Fli1表达降低而Gal-3升高,外周血单核细胞Gal-3蛋白和mRNA亦升高。
- 髓系Fli1敲除小鼠出现心肌纤维化和舒张功能障碍,老年小鼠收缩功能亦受损。
- Fli1缺失经Gal-3/mTORC1轴激活心脏成纤维细胞,抑制Gal-3或mTORC1可减轻活化。
核心结论
- 髓系细胞Fli1缺陷通过Gal-3依赖的mTORC1激活促进SSc心脏纤维化和功能障碍。
- 髓系Fli1-Gal-3-mTORC1轴是SSc相关心脏纤维化的核心通路和潜在治疗靶点。
研究设计与样本
- 对人SSc和对照心脏组织(n=6-7)行Fli1和Gal-3免疫组化,并分析循环单核细胞Gal-3蛋白和mRNA。
- 在年轻和老年髓系特异性Fli1敲除小鼠(Lyz2Cre/Fli1fl/fl)中通过胶原染色和超声心动图评估心脏纤维化和功能。
- 用人巨噬细胞与原发性人心脏成纤维细胞共培养,结合Fli1和Gal-3敲低、重组人Gal-3及雷帕霉素处理剖析mTORC1依赖的促纤维化信号。
主要发现
- 与对照相比,SSc心肌Fli1表达降低约6倍(P=0.0103),Gal-3升高约4倍(P=0.0031)。
- SSc单核细胞Gal-3蛋白升高约2倍(P=0.0235),mRNA升高约1.7倍(P=0.0448)。
- Lyz2Cre/Fli1fl/fl小鼠心肌胶原增加、二尖瓣E/e'升高(23.79±8.11 vs 18.76±8.09,P=0.04),收缩功能保留。
- 老年敲除小鼠纤维化进一步增加,左室射血分数降低(47.41±5.07 vs 66.15±11.49,P=0.0006)。
- Fli1缺失解除LGALS3启动子抑制使巨噬细胞Gal-3升高并激活心脏成纤维细胞mTORC1,抑制Gal-3或mTORC1可减弱成纤维细胞活化。
临床怎么用
- SSc患者心脏受累评估时可关注髓系Fli1-Gal-3-mTORC1轴作为潜在生物标志物方向。
- Gal-3或mTORC1抑制在实验体系中减弱成纤维细胞活化,提示可能为SSc心脏纤维化的治疗靶点。
局限性
- 人心脏组织样本量小(n=6-7),结论需更大样本验证。
- 机制证据主要来自小鼠模型和体外共培养实验,尚未在人体干预研究中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether down-regulation of the transcription factor Fli1 in myeloid cells, previously implicated in profibrotic programming in systemic sclerosis (SSc), promotes cardiac fibrosis and dysfunction in SSc and to define the underlying mechanisms. METHODS: Immunohistochemistry for Fli1 and galectin-3 (Gal-3) was performed on SSc and control cardiac tissue (n = 6-7). Circulating monocytes were analyzed for Gal-3 protein and messenger RNA (mRNA) levels. Cardiac fibrosis and function were evaluated in young and aged myeloid-specific Fli1 knockout mice (Lyz2Cre/Fli1fl/fl), by collagen staining and echocardiography. Co-culture experiments using human macrophages and primary human cardiac fibroblasts, Fli1 and Gal-3 knockdown, recombinant human Gal-3, and rapamycin were used to dissect mTORC1-dependent profibrotic signaling. RESULTS: Fli1 expression was reduced (~6-fold, P = 0.0103), whereas Gal-3 was increased (~4-fold, P = 0.0031) in SSc myocardium compared with control. SSc monocytes expressed elevated Gal-3 protein (~2-fold, P = 0.0235) and mRNA levels (~1.7-fold, P = 0.0448). Lyz2Cre /Fli1fl/fl mice had increased myocardial collagen and diastolic dysfunction with elevated mitral E/e' (23.79 ± 8.11 vs 18.76 ± 8.09, P = 0.04) but preserved systolic function; in aged mice, fibrosis was further increased, and systolic function was also impaired (left ventricular ejection fraction 47.41 ± 5.07 vs 66.15 ± 11.49, P = 0.0006). Mechanistically, Fli1 loss derepressed the LGALS3 promoter, increasing Gal-3 in macrophages and activating mTORC1 in cardiac fibroblasts, and Gal-3 or mTORC1 inhibition blunted fibroblast activation. CONCLUSION: Fli1 deficiency in myeloid cells drives Gal-3-dependent activation of mTORC1 in cardiac fibroblasts, promoting cardiac fibrosis and dysfunction in SSc. These findings identify a myeloid Fli1-Gal-3-mTORC1 axis as a central pathway in SSc-associated cardiac fibrosis and a potential therapeutic target.
引用
- El Adili F, Moyo KM, Vo H, et al. Down-Regulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis Via a Galectin-3/mTOR Dependent Pathway. Arthritis Rheumatol. 2026. PMID: 42681974. doi:10.1002/art.70299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。